The Effect of Esmolol Versus Dexmedetomidine on Postoperative Pain Control in Endoscopic Sinus Surgery: A Randomized Trial

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 30, 2022

Primary Completion Date

May 30, 2024

Study Completion Date

June 30, 2024

Conditions
Patient's SatisfactionDepth of Anesthesia
Interventions
DRUG

Esmolol Esterase

35 patients will be received i.v. received a loading dose of esmolol 0.5 mg/kg in 30 mL isotonic saline in the IV line, followed by an IV infusion of esmolol 0.05 mg/kg/min. infusion stopped immediately upon extubation.

DRUG

Dexmedetomidine

35 patients will be received dexmedetomidine (Precedex; Abbott Laboratories, North Chicago, Illinois, USA) (vial = 2 ml) 100 mcg/ml at bolus dose of 1 mcg /kg slowly infused over 10 min, then continuous infusion by a rate of 0. 5 mcg /kg/h., infused by a syringe pump. infusion stopped immediately upon extubation.

Trial Locations (1)

Unknown

RECRUITING

Faculty of Medicine, Tantan University Hospital, Tanta

All Listed Sponsors
lead

Tanta University

OTHER